genprowebdirectory
GEN Edge
Featured News
Multimedia
News
Insights
Trends for 2020
Trends for 2021
Trends for 2023
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
GEN Edge
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Videos
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Eye Disorders
Prime Editing Reverses Vision Loss in Mice
Artificial Intelligence
AI-Proofing Workflows in Drug Development
Cancer
New Drug Combo Reduces Lung Tumors in Mice
AgBio
Gene Discovery May Help Effort to Breed Climate Resilient Crops
Cancer
Novel Approach Delivers Therapeutic RNA Molecules to Selectively Target Cells
Insights
All
Trends for 2020
Trends for 2021
Trends for 2023
Cancer
Lightspeed’s Jonathan MacQuitty and the Laws of Biotech Relativity
Biologics
Biologics Manufacturing without the Cells
Bioprocessing
Bio-Inspired Coatings Could Make Cell Activation More Efficient in Therapy Production
Bioprocessing
Vortex-Focusing Microfluidics Yields Precisely Sized Liposomes at Scale
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
GEN Edge
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Drug Discovery
Seven Biopharma Trends to Watch in 2023
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Videos
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
Companies
Illumina
Illumina
23andMe
Abbvie
AdnaGen
Agilent Technologies
Alexion Pharmaceuticals
Amgen
Astellas
AstraZeneca
Audentes Therapeutics
Berkeley Lights
Bio-Rad Laboratories
Biogen
Cancer Genetics
Catalent
Charles RIver Laboratories
Dana-Farber Cancer Institute
deCODE genetics
Dicerna
Dimension Therapeutics
Exact Sciences
Foundation Medicine
GE Healthcare
GeneInsight
Gilead Sciences
GlaxoSmithKline
Halozyme Therapeutics
Hitachi High-Technologies
Horizon Discovery Group
Human Longevity
Illumina
Jackson Laboratory
Janssen Biotech
LabCorp
Maravai LifeSciences
MD Anderson
MDxHealth
MedImmune
Memorial Sloan Kettering Cancer Center
Merck & Co
Merck KGaA
NanoString Technologies
Novartis
Pathology
PerkinElmer
PersonalizeDx
Qiagen
RayBiotech
Roche
Sanofi
shire
Sigma-Aldrich
Synthego
Takeda
Thermo Fisher Scientific
UCB Biosciences
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Liquid Biopsies
StockWatch: Icahn Pursues Illumina Board Seats, and a Sell-Off of Grail
Next-Generation Sequencing
StockWatch: Analysts Mixed on Illumina after Q4 Results, Delivery of First NovaSeq X Plus System
Financing
EY Eyes Comeback for Biopharma M&A
Whole-Genome Analysis
At JPM, Illumina Announces African-American Sequencing Collaboration
Alzheimers
StockWatch: Analysts Sour on Roche after Alzheimer’s Clinical Failure
Illumina
Illumina Reveals New High-Throughput Instrument, NovaSeq X
Illumina
At Illumina Genomics Forum, Obama Prescribes Diversity, Resilience to Drive Precision...
Illumina
Illumina Predictions: What Will They Reveal at This Week’s Forum?
Illumina
StockWatch: Illumina Bounces Back After FTC Win, EU Loss
Illumina
Judge Sides with Illumina, Rejecting FTC Challenge to Grail Deal
Next-Generation Sequencing
X Marks the $100 Genome: Illumina Presents New Chemistry, Strong Results
Next-Generation Sequencing
Fast and Flexible: Singular’s G4 Takes Aim at Illumina’s Sequencing Superiority
Sequencing
Introducing “Close to the Edge”: A Zoom Conversation with PacBio CEO...
Illumina
Illumina Vows to Fight Back as FTC Takes Aim at $8B...
Illumina
Illumina Launching Pan-Cancer IVD Test, Cloud-Based Bioinformatics Platform
1
2
3
Page 1 of 3
Scroll Up